
Keywords: پیکروتوکسین; ACSF; artificial cerebrospinal fluid; CCh; carbachol; CPP; 3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate; EC; entorhinal cortex; GABAA; γ-aminobutyric acid type A receptor; LTP; long-term potentiation; MVSDs; moving standard deviations; NBQX; 2,3-dihy